Evidence map›Paper›PMID 39607450›Full record

ArticleEuropean radiology2025

Impact of intensity standardisation and ComBat batch size on clinical-radiomic prognostic models performance in a multi-centre study of patients with glioblastoma.

Kavi Fatania, Russell Frood, Hitesh Mistry, Susan C Short, James O'Connor, Andrew F Scarsbrook, Stuart Currie

Abstract readMulticenter Study
In one paragraph

Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kavi FataniaDepartment of Radiology, Leeds Teaching Hospitals NHS Trust, England, UK. Kavi.fatania@nhs.net.ORCID http://orcid.org/0000-0003-2421-1083
Russell FroodDepartment of Radiology, Leeds Teaching Hospitals NHS Trust, England, UK.
Hitesh MistryDivision of Cancer Sciences, University of Manchester, Manchester, UK.
Susan C ShortLeeds Institute of Medical Research, University of Leeds, Leeds, UK.
James O'ConnorDivision of Cancer Sciences, University of Manchester, Manchester, UK.
Andrew F ScarsbrookDepartment of Radiology, Leeds Teaching Hospitals NHS Trust, England, UK.
Stuart CurrieDepartment of Radiology, Leeds Teaching Hospitals NHS Trust, England, UK.

Funding

Cancer Research UK C19221/A22746Cancer Research UK RadNet; C19942/A28832Cancer Research UK RCCCTF-OCT22/100002Leeds Hospitals Charity 9R01/1403Wellcome TrustWellcome Trust 203914/Z/16/Z
6 · The paper itself

Abstract

purposeTo assess the effect of different intensity standardisation techniques (ISTs) and ComBat batch sizes on radiomics survival model performance and stability in a heterogenous, multi-centre cohort of patients with glioblastoma (GBM).

methodsMulti-centre pre-operative MRI acquired between 2014 and 2020 in patients with IDH-wildtype unifocal WHO grade 4 GBM were retrospectively evaluated. WhiteStripe (WS), Nyul histogram matching (HM), and Z-score (ZS) ISTs were applied before radiomic feature (RF) extraction. RFs were realigned using ComBat and minimum batch size (MBS) of 5, 10, or 15 patients. Cox proportional hazards models for overall survival (OS) prediction were produced using five different selection strategies and the impact of IST and MBS was evaluated using bootstrapping. Calibration, discrimination, relative explained variation, and model fit were assessed. Instability was evaluated using 95% confidence intervals (95% CIs), feature selection frequency and calibration curves across the bootstrap resamples.

resultsOne hundred ninety-five patients were included. Median OS = 13 (95% CI: 12-14) months. Twelve to fourteen unique MRI protocols were used per MRI sequence. HM and WS produced the highest relative increase in model discrimination, explained variation and model fit but IST choice did not greatly impact on stability, nor calibration. Larger ComBat batches improved discrimination, model fit, and explained variation but higher MBS (reduced sample size) reduced stability (across all performance metrics) and reduced calibration accuracy.

conclusionHeterogenous, real-world GBM data poses a challenge to the reproducibility of radiomics. ComBat generally improved model performance as MBS increased but reduced stability and calibration. HM and WS tended to improve model performance. KEY POINTS: Question ComBat harmonisation of RFs and intensity standardisation of MRI have not been thoroughly evaluated in multicentre, heterogeneous GBM data. Findings The addition of ComBat and ISTs can improve discrimination, relative model fit, and explained variance but degrades the calibration and stability of survival models. Clinical relevance Radiomics risk prediction models in real-world, multicentre contexts could be improved by ComBat and ISTs, however, this degrades calibration and prediction stability and this must be thoroughly investigated before patients can be accurately separated into different risk groups.

Indexed as

Brain NeoplasmsGlioblastomaMagnetic Resonance ImagingAdultAgedFemaleHumansMaleMiddle AgedPrognosisRadiomicsRetrospective StudiesBrain neoplasmsDiagnostic imagingGlioblastomaPrognosisRadiomics

Identifiers

PMID39607450
PMCPMC12081554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.